JPM
59
3
MKC
56
3
NSC
53
6
CTAS
53
3
RF
54
3
WDC
44
3
DG
27
-2
GD
44
2
EFX
40
4
CHD
45
3
O
33
-4
AEP
48
5
RCL
81
4
BIIB
38
2
MS
69
3
LMT
29
2
EQR
47
3
UPS
28
3
PEG
50
4
GT
60
13
JPM
59
3
MKC
56
3
NSC
53
6
CTAS
53
3
RF
54
3
WDC
44
3
DG
27
-2
GD
44
2
EFX
40
4
CHD
45
3
O
33
-4
AEP
48
5
RCL
81
4
BIIB
38
2
MS
69
3
LMT
29
2
EQR
47
3
UPS
28
3
PEG
50
4
GT
60
13
Financhill
Back

Veracyte Vs. OncoCyte Industry Stock Comparison

Buy
68

VCYT
Veracyte

Last Price:
36.31
Seasonality Move:
7.09%
Sell
43

OCX
OncoCyte

Last Price:
2.79
Seasonality Move:
66.51%
Buy
68
Veracyte (VCYT) is a Buy

Is Veracyte a Buy, Sell or Hold?

  • The current Veracyte [VCYT] share price is $35.93. The Score for VCYT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.92. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCYT Stock Price Chart

What is Veracyte's stock price today?

  • The Veracyte share price today is $35.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCYT is experiencing buying pressure, which is a positive indicator for future bullish movement.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight buying pressure.

VCYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 63.05 Buy
Chaikin Money Flow: 570249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.73 - 34.63) Buy
Bollinger Bands (100): (23.74 - 33.94) Buy

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 40.64 Sell
Chaikin Money Flow: 5897 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.97 - 3.11) Sell
Bollinger Bands (100): (2.9 - 3.2) Sell

VCYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.44 Buy
20-day SMA: 33.77 Buy
50-day SMA: 32.93 Buy
200-day SMA: 25.54 Buy
8-day EMA: 34.58 Buy
20-day EMA: 33.96 Buy
50-day EMA: 32.47 Buy
200-day EMA: 27.5 Buy

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.01 Sell
20-day SMA: 3.06 Sell
50-day SMA: 3.06 Sell
200-day SMA: 2.96 Sell
8-day EMA: 2.99 Sell
20-day EMA: 3.03 Sell
50-day EMA: 3.04 Sell
200-day EMA: 3.26 Sell

Veracyte Earnings Growth & VCYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.10 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

Veracyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):